ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag bird flu culture immunology ecology disease medicine

Deliberating Over Danger
The Scientist | Apr 1, 2012 | 10+ min read
The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Lurking in the Shadows
Bob Grant | Dec 1, 2014 | 10+ min read
Bats harbor diverse pathogens, including Ebola, Marburg, SARS, and MERS viruses. Understanding why could help researchers stymie deadly emerging diseases.
Researchers Finding Rewarding Careers As Software Entrepreneurs
Karen Hopkin | Jul 7, 1996 | 10 min read
Bacterium SIZE MATTERS: Deer ticks -- vectors of Borrelia Burgdorferi -- are half the size of the common dog tick, which is not associated with Lyme disease. As a new generation of adolescent deer tick enjoys its first blood meal, scientists in the United States and abroad continue to focus their research efforts on understanding and preventing Lyme disease. Ticks infected with the bacterium Borrelia burgdorferi cause more than 10,000 cases of Lyme disease in the U.S. each year, according to
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Vaccines: Victims of Their Own Success?
Ricki Lewis | Jul 18, 2004 | 10+ min read
Perhaps in no area is the divide between the developed and developing worlds as striking as it is for vaccines: While healthcare consumers in economically advantaged nations worry about risk, in developing nations compelling need forces a focus on potential benefit. "People in the United States want a quick solution, not prevention, so they prefer drugs to vaccines. Elsewhere, people are afraid of drugs and side effects, and prefer vaccines," says Shan Lu, a primary-care physician who has worked
In A Darwinian World, What Chance For Design?
Steve Bunk | Apr 12, 1998 | 7 min read
Swiss anthropologist Jeremy Narby counts himself among the relatively thin ranks of scientists willing to publicly announce their conviction that nature is "minded," that an intelligence lies behind the development of life. Such a position is heresy to the prevailing scientific view of naturalism, which holds that nature is self-sufficient and the result of undirected processes. These two differing viewpoints usually are framed in the context of a debate between theology and science--creationis

Run a Search

ADVERTISEMENT